Related Experiment Video

Updated: Aug 7, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression

H Jiang1, H S Chou, L Zhu

  • 1Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Molecular and Cellular Biology
|August 26, 1998
PubMed

Insights

Loss of p16INK4a function drives tumors. While p16INK4a and a Cdk4 mutant both inhibit cyclin D-dependent kinases, only p16INK4a causes cell cycle arrest by also inhibiting cyclin E-dependent kinases.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Oncology

Background:

  • Loss-of-function mutations in the p16INK4a gene are common in human tumors.
  • p16INK4a is known to inhibit cyclin D-dependent kinases, leading to G1 cell cycle arrest.
  • A Cdk4 mutant (Cdk4(N158)) designed to inhibit cyclin D-dependent kinases failed to induce cell cycle arrest.

Purpose of the Study:

  • To elucidate the functional differences between p16INK4a and Cdk4(N158).
  • To determine the precise mechanisms by which p16INK4a and Cdk4(N158) affect cell cycle progression.
  • To identify the key kinase activities required for p16INK4a-mediated growth suppression.

Main Methods:

  • Comparative analysis of p16INK4a and Cdk4(N158) in tumor cells.
  • Biochemical assays to assess kinase activity and protein complex formation.
  • Cellular studies involving overexpression of p16INK4a and cyclin E.

Main Results:

  • p16INK4a and Cdk4(N158) inhibit cyclin D1-Cdk4 complexes via distinct mechanisms.
  • p16INK4a dissociates cyclin D1-Cdk4, releasing p27KIP1, while Cdk4(N158) forms complexes with cyclin D1 and p27KIP1.
  • p16INK4a overexpression leads to p27KIP1 complexation with cyclin E-Cdk2, inhibiting Cdk2 activity.
  • Elevated cyclin E levels confer resistance to p16INK4a-mediated growth suppression.

Conclusions:

  • Inhibition of cyclin D-dependent kinase activity alone is insufficient for G1 arrest in proliferating tumor cells.
  • p16INK4a-mediated growth suppression requires the inhibition of both cyclin D- and cyclin E-dependent kinases.
  • Understanding these distinct mechanisms is crucial for developing targeted cancer therapies.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...